A. Delem

Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance

Nucleoside-modified mRNA vaccination partially overcomes maternal antibody inhibition of de novo immune responses in mice

Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013

Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial

Rotavirus Vaccines: Development, Current Issues and Future Prospects

Contagious Acute Gastrointestinal Infections

Effect of Human Rotavirus Vaccine on Severe Diarrhea in African Infants

Knowledge and intelligent computing system in medicine

Development of a rotavirus vaccine: Clinical safety, immunogenicity, and efficacy of the pentavalent rotavirus vaccine, RotaTeq®

Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective

Tho Sequential Outbreaks of Rotavirus Gastroenteritis: Evidence for Symptomatic and Asymptomatic Reinfections

Randomised placebo-controlled trial of rhesus-human reassortant rotavirus vaccine for prevention of severe rotavirus gastroenteritis

What Makes Clinical Research Ethical?

Mucosal immunity and vaccines

Vaccine hesitancy, vaccine refusal and the anti-vaccine movement: influence, impact and implications

Current status and future priorities for rotavirus vaccine development, evaluation and implementation in developing countries1Prepared as a review for the Consensus Workshop on Rotavirus Vaccines for use in Developing Countries, Geneva, January 9–10, 1997. Sponsored by: The Global Programme for Vaccines, World Health Organization, The Children's Vaccine Initiative and the Centers for Disease Control and Prevention.1

Immunity and correlates of protection for rotavirus vaccines

Human nutrition, the gut microbiome and the immune system

Age‐dependent variation in the serum concentration of mannan‐binding protein

Rotavirus

Association Between Pentavalent Rotavirus Vaccine and Severe Rotavirus Diarrhea Among Children in Nicaragua

Safety, immunogenicity, and protective efficacy of two doses of RIX4414 live attenuated human rotavirus vaccine in healthy Brazilian infants

Effect of Small Bowel Bacterial Overgrowth on the Immunogenicity of Single‐Dose Live Oral Cholera Vaccine CVD 103‐HgR

IMMUNE RESPONSES TO VARICELLA-ZOSTER VIRUS

The Role of Serum Antibodies in the Protection against Rotavirus Disease: An Overview

Transplacental rotavirus IgG interferes with immune response to live oral rotavirus vaccine ORV-116E in Indian infants

Inactivated rotavirus vaccines: A priority for accelerated vaccine development

Innate immunity of the newborn: basic mechanisms and clinical correlates

Chicken Antibodies: Taking Advantage of Evolution—A Review

2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-analysis

First rotavirus vaccine licensed: Is there really a need?

Rotavirus vaccines—An update

Vaccine hesitancy

Determinants of parents' decision to vaccinate their children against rotavirus: results of a longitudinal study

Rotavirus Disease in Finnish Children: Use of Numerical Scores for Clinical Severity of Diarrhoeal Episodes

Rotavirus Infection in Infants as Protection against Subsequent Infections

How many child deaths can we prevent this year?

Rotavirus vaccines: viral shedding and risk of transmission

Interventions for the control of diarrhoeal diseases among young children: rotavirus and cholera immunization.

Bovine milk immunoglobulins for passive immunity to infantile rotavirus gastroenteritis

Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010.

Identification of the two rotavirus genes determining neutralization specificities

Identification of group A rotavirus gene 4 types by polymerase chain reaction

Safety and Immunogenicity of Concurrent Administration of Live Attenuated Influenza Vaccine With Measles-Mumps-Rubella and Varicella Vaccines to Infants 12 to 15 Months of Age

Modeling the Risk From Giardia and Viruses in Drinking Water

Gastroenteritis in Suckling Mice Caused by Human Rotavirus Can Be Prevented with Egg Yolk Immunoglobulin (IgY) and Treated with a Protein‐Bound Polysaccharide Preparation (PSK)

Rectal Immunization with Rotavirus Virus-Like Particles Induces Systemic and Mucosal Humoral Immune Responses and Protects Mice against Rotavirus Infection

Rotavirus and Severe Childhood Diarrhea

Varicella-zoster virus

Distribution of serotypes of human rotavirus in different populations

Marked sequence variation between segment 4 genes of human RV-5 and simian SA 11 rotaviruses

Causes of neonatal and child mortality in India: a nationally representative mortality survey

Annual Rotavirus Epidemic Patterns in North America

Human Rotavirus Studies in Volunteers: Determination of Infectious Dose and Serological Response to Infection

Comparison of rotavirus immunoglobulin A coproconversion with other indices of rotavirus infection in a longitudinal study in childhood

Global Illness and Deaths Caused by Rotavirus Disease in Children

Vaccines for preventing influenza in healthy children

2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host

Cost and Cost-Effectiveness of Childhood Vaccination against Rotavirus in France.

Prevention of Rotavirus Gastroenteritis Among Infants and Children: Recommendations of the Advisory Committee on Immunization Practices (ACIP)

Complete nucleotide sequence of the gene encoding VP4 of a human rotavirus (strain K8) which has unique VP4 neutralization epitopes

Industry sponsorship and research outcome

Segurança, imunogenicidade e eficácia protetora de duas doses da vacina RIX4414 contendo rotavírus atenuado de origem humana

Direct Serotyping of Human Rotavirus in Stools by an Enzyme-Linked Immunosorbent Assay Using Serotype 1-, 2-, 3-, and 4-Specific Monoclonal Antibodies to VP7

Correlates of Protection Induced by Vaccination

Factors Affecting Antibody Response of Newborns to Repeated Administrations of the Rotavirus Vaccine RIT 4237

Evaluation of Live Attenuated Varicella Vaccine (Oka‐RIT Strain) and Combined Varicella and MMR Vaccination in 13–17‐Month‐Old Children

Successful co-administration of a human rotavirus and oral poliovirus vaccines in Bangladeshi infants in a 2-dose schedule at 12 and 16 weeks of age

Comparison of 2 Different Regimens for Reactogenicity, Safety, and Immunogenicity of the Live Attenuated Oral Rotavirus Vaccine RIX4414 Coadministered with Oral Polio Vaccine in South African Infants

Evaluation of RIT 4237 Bovine Rotavirus Vaccine in Newborn Infants: Correlation of Vaccine Efficacy to Season of Birth in Relation to Rotavirus Epidemic Period

Efficacy of RIX4414 Live Attenuated Human Rotavirus Vaccine in Finnish Infants

Immunogenicity, reactogenicity and safety of human rotavirus vaccine (RIX4414) in Indian infants

Safety, Reactogenicity, and Immunogenicity of Human Rotavirus Vaccine RIX4414 in Human Immunodeficiency Virus-positive Infants in South Africa

Safety and immunogenicity of RIX4414 live attenuated human rotavirus vaccine in adults, toddlers and previously uninfected infants

Efficacy of Two Doses of RIT 4237 Bovine Rotavirus Vaccine for Prevention of Rotavirus Diarrhoea

A Rotavirus Vaccine for Prophylaxis of Infants Against Rotavirus Gastroenteritis

Detection of serum antibody responses to RIT 4237 rotavirus vaccine by ELISA and neutralization assays

Clinical efficacy of the RIT 4237 live attenuated bovine rotavirus vaccine in infants vaccinated before a rotavirus epidemic

Dose-response study of RIT 4237 oral rotavirus vaccine in breast-fed and formula-fed infants

PROTECTION OF INFANTS AGAINST ROTAVIRUS DIARRHOEA BY RIT 4237 ATTENUATED BOVINE ROTAVIRUS STRAIN VACCINE

Immunogenicity, Reactogenicity and Safety of the Oral Live Attenuated Human Rotavirus Vaccine RIX4414(Rotarix™) Oral Suspension (Liquid Formulation) in Vietnamese Infants

Protection Studies in Colostrum-Deprived Piglets of a Bovine Rotavirus Vaccine Candidate Using Human Rotavirus Strains for Challenge

Protective efficacy of live influenza vaccines. Its assessment in field and experimental conditions.

Combined vaccination with live oral polio vaccine and the bovine rotavirus RIT 4237 strain

Neonatal rotavirus vaccination with RIT 4237 bovine rotavirus vaccine

A Comparative Trial of Rhesus Monkey (RRV-1) and Bovine (RIT 4237) Oral Rotavirus Vaccines in Young Children